Global Diagnostic Nuclear Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 192587
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Diagnostic Nuclear Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Diagnostic Nuclear Drug size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Diagnostic Nuclear Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Diagnostic Nuclear Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Tc-99m

F-18

Other

Market segment by Application, can be divided into

Oncology

Cardiology

Other

Market segment by players, this report covers

Bracco Imaging

Bayer

Curium Pharmaceuticals

Nordion

Triad Isotopes

Lantheus

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Novartis

SIEMENS

Dongcheng

Navidea

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Diagnostic Nuclear Drug

1.2 Classification of Diagnostic Nuclear Drug by Type

1.2.1 Overview: Global Diagnostic Nuclear Drug Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Diagnostic Nuclear Drug Revenue Market Share by Type in 2020

1.2.3 Tc-99m

1.2.4 F-18

1.2.5 Other

1.3 Global Diagnostic Nuclear Drug Market by Application

1.3.1 Overview: Global Diagnostic Nuclear Drug Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Diagnostic Nuclear Drug Market Size & Forecast

1.5 Global Diagnostic Nuclear Drug Market Size and Forecast by Region

1.5.1 Global Diagnostic Nuclear Drug Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Diagnostic Nuclear Drug Market Size by Region, (2016-2021)

1.5.3 North America Diagnostic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.4 Europe Diagnostic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Diagnostic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.6 South America Diagnostic Nuclear Drug Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Diagnostic Nuclear Drug Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Diagnostic Nuclear Drug Market Drivers

1.6.2 Diagnostic Nuclear Drug Market Restraints

1.6.3 Diagnostic Nuclear Drug Trends Analysis

2 Company Profiles

2.1 Bracco Imaging

2.1.1 Bracco Imaging Details

2.1.2 Bracco Imaging Major Business

2.1.3 Bracco Imaging Diagnostic Nuclear Drug Product and Solutions

2.1.4 Bracco Imaging Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Bracco Imaging Recent Developments and Future Plans

2.2 Bayer

2.2.1 Bayer Details

2.2.2 Bayer Major Business

2.2.3 Bayer Diagnostic Nuclear Drug Product and Solutions

2.2.4 Bayer Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bayer Recent Developments and Future Plans

2.3 Curium Pharmaceuticals

2.3.1 Curium Pharmaceuticals Details

2.3.2 Curium Pharmaceuticals Major Business

2.3.3 Curium Pharmaceuticals Diagnostic Nuclear Drug Product and Solutions

2.3.4 Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Curium Pharmaceuticals Recent Developments and Future Plans

2.4 Nordion

2.4.1 Nordion Details

2.4.2 Nordion Major Business

2.4.3 Nordion Diagnostic Nuclear Drug Product and Solutions

2.4.4 Nordion Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Nordion Recent Developments and Future Plans

2.5 Triad Isotopes

2.5.1 Triad Isotopes Details

2.5.2 Triad Isotopes Major Business

2.5.3 Triad Isotopes Diagnostic Nuclear Drug Product and Solutions

2.5.4 Triad Isotopes Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Triad Isotopes Recent Developments and Future Plans

2.6 Lantheus

2.6.1 Lantheus Details

2.6.2 Lantheus Major Business

2.6.3 Lantheus Diagnostic Nuclear Drug Product and Solutions

2.6.4 Lantheus Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Lantheus Recent Developments and Future Plans

2.7 GE Healthcare

2.7.1 GE Healthcare Details

2.7.2 GE Healthcare Major Business

2.7.3 GE Healthcare Diagnostic Nuclear Drug Product and Solutions

2.7.4 GE Healthcare Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 GE Healthcare Recent Developments and Future Plans

2.8 China Isotope & Radiation

2.8.1 China Isotope & Radiation Details

2.8.2 China Isotope & Radiation Major Business

2.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Product and Solutions

2.8.4 China Isotope & Radiation Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 China Isotope & Radiation Recent Developments and Future Plans

2.9 Jubilant Pharma

2.9.1 Jubilant Pharma Details

2.9.2 Jubilant Pharma Major Business

2.9.3 Jubilant Pharma Diagnostic Nuclear Drug Product and Solutions

2.9.4 Jubilant Pharma Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Jubilant Pharma Recent Developments and Future Plans

2.10 Eli Lilly

2.10.1 Eli Lilly Details

2.10.2 Eli Lilly Major Business

2.10.3 Eli Lilly Diagnostic Nuclear Drug Product and Solutions

2.10.4 Eli Lilly Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Eli Lilly Recent Developments and Future Plans

2.11 Novartis

2.11.1 Novartis Details

2.11.2 Novartis Major Business

2.11.3 Novartis Diagnostic Nuclear Drug Product and Solutions

2.11.4 Novartis Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Novartis Recent Developments and Future Plans

2.12 SIEMENS

2.12.1 SIEMENS Details

2.12.2 SIEMENS Major Business

2.12.3 SIEMENS Diagnostic Nuclear Drug Product and Solutions

2.12.4 SIEMENS Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 SIEMENS Recent Developments and Future Plans

2.13 Dongcheng

2.13.1 Dongcheng Details

2.13.2 Dongcheng Major Business

2.13.3 Dongcheng Diagnostic Nuclear Drug Product and Solutions

2.13.4 Dongcheng Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Dongcheng Recent Developments and Future Plans

2.14 Navidea

2.14.1 Navidea Details

2.14.2 Navidea Major Business

2.14.3 Navidea Diagnostic Nuclear Drug Product and Solutions

2.14.4 Navidea Diagnostic Nuclear Drug Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Navidea Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Diagnostic Nuclear Drug Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Diagnostic Nuclear Drug Players Market Share

3.2.2 Top 10 Diagnostic Nuclear Drug Players Market Share

3.2.3 Market Competition Trend

3.3 Diagnostic Nuclear Drug Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Diagnostic Nuclear Drug Revenue and Market Share by Type (2016-2021)

4.2 Global Diagnostic Nuclear Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Diagnostic Nuclear Drug Revenue Market Share by Application (2016-2021)

5.2 Diagnostic Nuclear Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Diagnostic Nuclear Drug Revenue by Type (2016-2026)

6.2 North America Diagnostic Nuclear Drug Revenue by Application (2016-2026)

6.3 North America Diagnostic Nuclear Drug Market Size by Country

6.3.1 North America Diagnostic Nuclear Drug Revenue by Country (2016-2026)

6.3.2 United States Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

6.3.3 Canada Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

6.3.4 Mexico Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Diagnostic Nuclear Drug Revenue by Type (2016-2026)

7.2 Europe Diagnostic Nuclear Drug Revenue by Application (2016-2026)

7.3 Europe Diagnostic Nuclear Drug Market Size by Country

7.3.1 Europe Diagnostic Nuclear Drug Revenue by Country (2016-2026)

7.3.2 Germany Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.3 France Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.5 Russia Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

7.3.6 Italy Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Diagnostic Nuclear Drug Revenue by Type (2016-2026)

8.2 Asia-Pacific Diagnostic Nuclear Drug Revenue by Application (2016-2026)

8.3 Asia-Pacific Diagnostic Nuclear Drug Market Size by Region

8.3.1 Asia-Pacific Diagnostic Nuclear Drug Revenue by Region (2016-2026)

8.3.2 China Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.3 Japan Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.4 South Korea Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.5 India Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

8.3.7 Australia Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Diagnostic Nuclear Drug Revenue by Type (2016-2026)

9.2 South America Diagnostic Nuclear Drug Revenue by Application (2016-2026)

9.3 South America Diagnostic Nuclear Drug Market Size by Country

9.3.1 South America Diagnostic Nuclear Drug Revenue by Country (2016-2026)

9.3.2 Brazil Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

9.3.3 Argentina Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Diagnostic Nuclear Drug Revenue by Type (2016-2026)

10.2 Middle East & Africa Diagnostic Nuclear Drug Revenue by Application (2016-2026)

10.3 Middle East & Africa Diagnostic Nuclear Drug Market Size by Country

10.3.1 Middle East & Africa Diagnostic Nuclear Drug Revenue by Country (2016-2026)

10.3.2 Turkey Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

10.3.4 UAE Diagnostic Nuclear Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Diagnostic Nuclear Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Diagnostic Nuclear Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Diagnostic Nuclear Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Diagnostic Nuclear Drug Revenue (USD Million) by Region (2016-2021)

Table 5. Global Diagnostic Nuclear Drug Revenue Market Share by Region (2021-2026)

Table 6. Bracco Imaging Corporate Information, Head Office, and Major Competitors

Table 7. Bracco Imaging Major Business

Table 8. Bracco Imaging Diagnostic Nuclear Drug Product and Solutions

Table 9. Bracco Imaging Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bayer Corporate Information, Head Office, and Major Competitors

Table 11. Bayer Major Business

Table 12. Bayer Diagnostic Nuclear Drug Product and Solutions

Table 13. Bayer Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Curium Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 15. Curium Pharmaceuticals Major Business

Table 16. Curium Pharmaceuticals Diagnostic Nuclear Drug Product and Solutions

Table 17. Curium Pharmaceuticals Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Nordion Corporate Information, Head Office, and Major Competitors

Table 19. Nordion Major Business

Table 20. Nordion Diagnostic Nuclear Drug Product and Solutions

Table 21. Nordion Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Triad Isotopes Corporate Information, Head Office, and Major Competitors

Table 23. Triad Isotopes Major Business

Table 24. Triad Isotopes Diagnostic Nuclear Drug Product and Solutions

Table 25. Triad Isotopes Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Lantheus Corporate Information, Head Office, and Major Competitors

Table 27. Lantheus Major Business

Table 28. Lantheus Diagnostic Nuclear Drug Product and Solutions

Table 29. Lantheus Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 31. GE Healthcare Major Business

Table 32. GE Healthcare Diagnostic Nuclear Drug Product and Solutions

Table 33. GE Healthcare Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. China Isotope & Radiation Corporate Information, Head Office, and Major Competitors

Table 35. China Isotope & Radiation Major Business

Table 36. China Isotope & Radiation Diagnostic Nuclear Drug Product and Solutions

Table 37. China Isotope & Radiation Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Jubilant Pharma Corporate Information, Head Office, and Major Competitors

Table 39. Jubilant Pharma Major Business

Table 40. Jubilant Pharma Diagnostic Nuclear Drug Product and Solutions

Table 41. Jubilant Pharma Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 43. Eli Lilly Major Business

Table 44. Eli Lilly Diagnostic Nuclear Drug Product and Solutions

Table 45. Eli Lilly Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Novartis Corporate Information, Head Office, and Major Competitors

Table 47. Novartis Major Business

Table 48. Novartis Diagnostic Nuclear Drug Product and Solutions

Table 49. Novartis Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. SIEMENS Corporate Information, Head Office, and Major Competitors

Table 51. SIEMENS Major Business

Table 52. SIEMENS Diagnostic Nuclear Drug Product and Solutions

Table 53. SIEMENS Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Dongcheng Corporate Information, Head Office, and Major Competitors

Table 55. Dongcheng Major Business

Table 56. Dongcheng Diagnostic Nuclear Drug Product and Solutions

Table 57. Dongcheng Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Navidea Corporate Information, Head Office, and Major Competitors

Table 59. Navidea Major Business

Table 60. Navidea Diagnostic Nuclear Drug Product and Solutions

Table 61. Navidea Diagnostic Nuclear Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Diagnostic Nuclear Drug Revenue (USD Million) by Players (2019-2021)

Table 63. Global Diagnostic Nuclear Drug Revenue Share by Players (2019-2021)

Table 64. Breakdown of Diagnostic Nuclear Drug by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Diagnostic Nuclear Drug Players Head Office, Products and Services Provided

Table 66. Diagnostic Nuclear Drug Mergers & Acquisitions in the Past Five Years

Table 67. Diagnostic Nuclear Drug New Entrants and Expansion Plans

Table 68. Global Diagnostic Nuclear Drug Revenue (USD Million) by Type (2016-2021)

Table 69. Global Diagnostic Nuclear Drug Revenue Share by Type (2016-2021)

Table 70. Global Diagnostic Nuclear Drug Revenue Forecast by Type (2021-2026)

Table 71. Global Diagnostic Nuclear Drug Revenue by Application (2016-2021)

Table 72. Global Diagnostic Nuclear Drug Revenue Forecast by Application (2021-2026)

Table 73. North America Diagnostic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Diagnostic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Diagnostic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Diagnostic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Diagnostic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Diagnostic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Diagnostic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Diagnostic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Diagnostic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Diagnostic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Diagnostic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Diagnostic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Diagnostic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Diagnostic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Diagnostic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Diagnostic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Diagnostic Nuclear Drug Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Diagnostic Nuclear Drug Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Diagnostic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Diagnostic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Diagnostic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Diagnostic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Diagnostic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Diagnostic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Diagnostic Nuclear Drug Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Diagnostic Nuclear Drug Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Diagnostic Nuclear Drug Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Diagnostic Nuclear Drug Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Diagnostic Nuclear Drug Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Diagnostic Nuclear Drug Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Diagnostic Nuclear Drug Picture

Figure 2. Global Diagnostic Nuclear Drug Revenue Market Share by Type in 2020

Figure 3. Tc-99m

Figure 4. F-18

Figure 5. Other

Figure 6. Diagnostic Nuclear Drug Revenue Market Share by Application in 2020

Figure 7. Oncology Picture

Figure 8. Cardiology Picture

Figure 9. Other Picture

Figure 10. Global Diagnostic Nuclear Drug Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Diagnostic Nuclear Drug Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Diagnostic Nuclear Drug Revenue Market Share by Region (2016-2026)

Figure 13. Global Diagnostic Nuclear Drug Revenue Market Share by Region in 2020

Figure 14. North America Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Diagnostic Nuclear Drug Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Diagnostic Nuclear Drug Market Drivers

Figure 20. Diagnostic Nuclear Drug Market Restraints

Figure 21. Diagnostic Nuclear Drug Market Trends

Figure 22. Bracco Imaging Recent Developments and Future Plans

Figure 23. Bayer Recent Developments and Future Plans

Figure 24. Curium Pharmaceuticals Recent Developments and Future Plans

Figure 25. Nordion Recent Developments and Future Plans

Figure 26. Triad Isotopes Recent Developments and Future Plans

Figure 27. Lantheus Recent Developments and Future Plans

Figure 28. GE Healthcare Recent Developments and Future Plans

Figure 29. China Isotope & Radiation Recent Developments and Future Plans

Figure 30. Jubilant Pharma Recent Developments and Future Plans

Figure 31. Eli Lilly Recent Developments and Future Plans

Figure 32. Novartis Recent Developments and Future Plans

Figure 33. SIEMENS Recent Developments and Future Plans

Figure 34. Dongcheng Recent Developments and Future Plans

Figure 35. Navidea Recent Developments and Future Plans

Figure 36. Global Diagnostic Nuclear Drug Revenue Share by Players in 2020

Figure 37. Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Diagnostic Nuclear Drug Revenue Market Share in 2020

Figure 39. Global Top 10 Players Diagnostic Nuclear Drug Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Diagnostic Nuclear Drug Revenue Share by Type in 2020

Figure 42. Global Diagnostic Nuclear Drug Market Share Forecast by Type (2021-2026)

Figure 43. Global Diagnostic Nuclear Drug Revenue Share by Application in 2020

Figure 44. Global Diagnostic Nuclear Drug Market Share Forecast by Application (2021-2026)

Figure 45. North America Diagnostic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 46. North America Diagnostic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 47. North America Diagnostic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 48. United States Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Diagnostic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 52. Europe Diagnostic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 53. Europe Diagnostic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 54. Germany Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Diagnostic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Diagnostic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Diagnostic Nuclear Drug Revenue Market Share by Region (2016-2026)

Figure 62. China Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Diagnostic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 69. South America Diagnostic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 70. South America Diagnostic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Diagnostic Nuclear Drug Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Diagnostic Nuclear Drug Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Diagnostic Nuclear Drug Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Diagnostic Nuclear Drug Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz